AG
Artal Group Portfolio holdings
AUM
$930M
1-Year Return
3.57%
This Quarter Return
+16.3%
1 Year Return
-3.57%
3 Year Return
+157.23%
5 Year Return
+160.22%
10 Year Return
+1,359.85%
AUM
$5.04B
AUM Growth
+$522M
(+12%)
Cap. Flow
-$114M
Cap. Flow
% of AUM
-2.26%
Top 10 Holdings %
Top 10 Hldgs %
92.8%
Holding
109
New
12
Increased
18
Reduced
24
Closed
12
Top Buys
| 1 |
CLVS
Clovis Oncology, Inc.
CLVS
|
$7.42M |
| 2 |
ARRY
Array Biopharma Inc
ARRY
|
$6.77M |
| 3 |
GBT
Global Blood Therapeutics, Inc.
GBT
|
$6.21M |
| 4 |
BOLD
Audentes Therapeutics, Inc
BOLD
|
$5.6M |
| 5 |
ProQR Therapeutics
PRQR
|
$4.85M |
Top Sells
| 1 |
Goldman Sachs
GS
|
$22.2M |
| 2 |
ONC
BeOne Medicines Ltd. American Depositary Shares
ONC
|
$18.1M |
| 3 |
Agios Pharmaceuticals
AGIO
|
$16.7M |
| 4 |
BLUE
bluebird bio
BLUE
|
$15.8M |
| 5 |
ALXN
Alexion Pharmaceuticals Inc
ALXN
|
$12.2M |
Sector Composition
| 1 | Consumer Staples | 49.27% |
| 2 | Consumer Discretionary | 25.43% |
| 3 | Healthcare | 24.54% |
| 4 | Financials | 0% |
| 5 | Industrials | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Sarepta Therapeutics
SRPT
$1.92B
| $9.07M | 0.16% |
200,000
+50,000
| +33% | +$2.27M |
|
27
Seres Therapeutics
MCRB
$159M
| $8.82M | 0.15% |
27,500
-2,500
| -8% | -$802K |
|
|
28
ProQR Therapeutics
PRQR
$250M
| $7.28M | 0.13% |
1,500,000
+1,000,000
| +200% | +$4.85M |
|
|
JUNO
29
DELISTED
Juno Therapeutics, Inc.
JUNO
| $6.73M | 0.12% |
150,000
-50,000
| -25% | -$2.24M |
|
|
HZNP
30
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
| $6.34M | 0.11% |
500,000
-260,000
| -34% | -$3.3M |
|
|
ALDR
31
DELISTED
Alder Biopharmaceuticals, Inc.
ALDR
| $6.13M | 0.11% |
500,000
+200,000
| +67% | +$2.45M |
|
|
BOLD
32
DELISTED
Audentes Therapeutics, Inc
BOLD
| $5.6M | 0.1% |
+200,000
| New | +$5.6M |
|
33
AC Immune
ACIU
$219M
| $5.59M | 0.1% |
500,000
| – | – |
|
34
Regenxbio
RGNX
$475M
| $5.27M | 0.09% |
160,000
| – | – |
|
35
AnaptysBio
ANAB
$637M
| $5.24M | 0.09% |
150,000
-100,000
| -40% | -$3.5M |
|
36
TG Therapeutics
TGTX
$4.93B
| $4.74M | 0.08% |
400,000
-100,000
| -20% | -$1.19M |
|
37
e.l.f. Beauty
ELF
$7.73B
| $4.51M | 0.08% |
200,000
-50,000
| -20% | -$1.13M |
|
|
AXDX
38
DELISTED
Accelerate Diagnostics
AXDX
| $4.49M | 0.08% |
20,000
| – | – |
|
|
ACHN
39
DELISTED
Achillion Pharmaceuticals, Inc.
ACHN
| $4.49M | 0.08% |
+1,000,000
| New | +$4.49M |
|
40
Immunic
IMUX
$76M
| $4.42M | 0.08% |
21,875
| – | – |
|
41
Intellia Therapeutics
NTLA
$1.22B
| $4.35M | 0.07% |
175,000
-75,000
| -30% | -$1.86M |
|
|
ADAP
42
Adaptimmune Therapeutics
ADAP
$13M
| $4.1M | 0.07% |
500,000
+200,000
| +67% | +$1.64M |
|
|
AKAO
43
DELISTED
Achaogen, Inc.
AKAO
| $3.99M | 0.07% |
250,000
+50,000
| +25% | +$798K |
|
|
CCXI
44
DELISTED
ChemoCentryx, Inc.
CCXI
| $3.71M | 0.06% |
500,000
| – | – |
|
45
MacroGenics
MGNX
$121M
| $3.7M | 0.06% |
200,000
-100,000
| -33% | -$1.85M |
|
46
Lineage Cell Therapeutics
LCTX
$274M
| $3.64M | 0.06% |
1,465,383
| – | – |
|
47
Verastem
VSTM
$601M
| $3.53M | 0.06% |
62,500
+20,833
| +50% | +$1.17M |
|
48
Larimar Therapeutics
LRMR
$324M
| $3.52M | 0.06% |
83,333
| – | – |
|
|
SIOX
49
DELISTED
Sio Gene Therapies Inc. Common Stock
SIOX
| $3.44M | 0.06% |
62,500
+40,625
| +186% | +$2.24M |
|
50
BioCryst Pharmaceuticals
BCRX
$1.73B
| $3.41M | 0.06% |
650,000
-200,000
| -24% | -$1.05M |
|